Psychosis

The Myth of Schizophrenia as a Progressive Brain Disease

Schizophrenia has historically been considered to be a deteriorating disease, a view reinforced by recent MRI findings of progressive brain […]

Read More
By R Kennedy | Chronic illness . Neuroscience . News . Psychosis . Schizophrenia
DETAIL

Sixth Annual Chair Summit Begins This Week

This week a Master Class for Neuroscience Development called the Chair Summit takes place in Tampa, FL (Sept 26-28, 2013). […]

Read More
By R Kennedy | Addiction . ADHD . Antipsychotic medication . Anxiety Disorders . Biomarker . Bipolar Disorder . Cardiovascular Risk Factors . Chronic Pain . CME . Dementia . Depression . Diabetes . Diagnosis . Digital medicine . Drug Development . Drugs . DSM-5 . Early intervention . Education . Food . Genetics . Guideline . Imaging . Maintenance of Certification . Measurement-based care . Medical Education . Mood . MRI . Multiple sclerosis . Negative symptoms . Neuroscience . Obesity . Opioids . PET . Practice guideline . Psychosis . PTSD . Research . Schizophrenia . Smoking cessation . Social media . Stroke . Substance abuse . Transcranial magnetic stimulation . Vascular dementia
DETAIL

Essential Components of First-Episode Psychosis Services

A study published in May 1st, 2013 Psychiatric Services identified essential evidence-based components of first-episode psychosis services. The research took […]

Read More
By R Kennedy | Addiction . Adherence . Antipsychotic medication . Early intervention . Measurement-based care . Mental health . Metabolic screening . Professionalism . Psychosis . Schizophrenia
DETAIL

The Nature of Relapse in Schizophrenia

Discontinuation of treatment in schizophrenia results in very high relapse rates, even after a single psychotic episode. A new review […]

Read More
By R Kennedy | Adherence . Antipsychotic medication . Neuroscience . Psychosis . Relapse . Schizophrenia
DETAIL

Non-adherence to Antipsychotics and Cardiometabolic Medication Result in Health Care Utilization and Costs

A new study in Psychiatric Services examined the association between adherence to antipsychotic and cardiometabolic medication and the use of […]

Read More
By R Kennedy | Adherence . Antipsychotic medication . Cardiovascular Risk Factors . Metabolic screening . Psychosis . Schizophrenia
DETAIL

Early Detection and Intervention in Psychosis Improves 10-Year Outcome

Early detection in first-episode psychosis confers advantages for negative, cognitive, and depressive symptoms after 1, 2, and 5 years, but […]

Read More
By R Kennedy | Early intervention . Negative symptoms . Psychosis . Schizophrenia . Treatment
DETAIL

Chair Summit Meeting Highlights – available now in HORM

Article series from the 3rd Annual Chair Summit, The Master Class for Neuroscience Professional Development (Chair Summit) available now in […]

Read More
By R Kennedy | Alzheimer's Disease . CME . Medical Education . Mood . Multiple sclerosis . Neuroscience . Psychosis . Schizophrenia . Sleep
DETAIL

Persistent negative symptoms in first-episode schizophrenia

A study published in Schizophrenia Research describes that negative symptoms, which are a core feature of schizophrenia, are generally understudied. […]

Read More
By R Kennedy | Negative symptoms . Psychosis . Schizophrenia
DETAIL
This site uses cookies: Find out more.